SRA
Summit Rock Advisors Portfolio holdings
AUM
$355K
This Quarter Return
+23.97%
1 Year Return
+15.32%
3 Year Return
+85.97%
5 Year Return
+180.9%
10 Year Return
+226.74%
AUM
$163M
AUM Growth
+$163M
(-2.4%)
Cap. Flow
-$1.81M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
–
Closed
2
Top Buys
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$109M |
| 2 |
Vanguard Total World Stock ETF
VT
|
$3.17M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
$3.13M |
Top Sells
| 1 |
Vanguard Value ETF
VTV
|
$60.9M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
$56.5M |
Sector Composition
| 1 | Healthcare | 1.15% |
| 2 | Technology | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Energy Select Sector SPDR Fund
XLE
$27.6B
| $109M | 66.85% | +1,429,749 | New | +$109M |
|
|
2
iShares Russell 2000 Value ETF
IWN
$11.8B
| $48.9M | 29.9% | 302,850 +19,378 | +7% | +$3.13M |
|
|
3
Vanguard Total World Stock ETF
VT
$51.6B
| $3.17M | 1.94% | +31,329 | New | +$3.17M |
|
4
Clover Health Investments
CLOV
$1.34B
| $748K | 0.46% | 210,639 | – | – |
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $464K | 0.28% | 34,100 | – | – |
|
6
Dyne Therapeutics
DYN
$1.92B
| $336K | 0.21% | 34,887 | – | – |
|
7
Day One Biopharmaceuticals
DAWN
$769M
| $329K | 0.2% | 33,125 | – | – |
|
8
monday.com
MNDY
$9.95B
| $265K | 0.16% | 1,676 | – | – |
|
|
9
iShares Core S&P US Value ETF
IUSV
$22B
| – | – | -740,195 | Closed | -$56.5M |
|
|
10
Vanguard Value ETF
VTV
$144B
| – | – | -413,962 | Closed | -$60.9M |
|